natgillin/translations-raw huggingface dataset:
No data are available on the efficacy of ulipristal acetate when taken more than 120 hours (5 days) after unprotected intercourse. 
Na voljo ni podatkov o učinkovitosti ulipristalacetata pri ženskah, ki so ga zaužile več kot 120 ur (5 dni) po nezaščitenem spolnem odnosu.
Ulipristal acetate for emergency contraception is suitable for any woman of child bearing age, including adolescents. 
Ulipristal acetat za nujno kontracepcijo je primeren za vsako žensko v rodni dobi, vključno z mladostnicami.
ellaOne is available in a carton containing one blister of 1 film-coated tablet. 
Zdravilo ellaOne je na voljo v škatli, ki vsebuje en pretisni omot z 1 filmsko obloženo tableto.
However, if your period is more than 7 days late; if it is unusually light or unusually heavy; or if you experience symptoms such as abdominal (stomach) pain, breast tenderness, vomiting or nausea, you may be pregnant. 
Vendar če zamuja za več kot 7 dni, če je nenavadno šibka ali močna ali če opazite simptome, kot so bolečine v trebuhu, občutljive dojke, bruhanje ali slabost s siljenjem na bruhanje, ste morda noseči.
The most commonly reported adverse reactions were headache, nausea, abdominal pain and dysmenorrhea. 
Najpogostejši neželeni učinki, o katerih so poročali, so bili glavobol, navzea, bolečina v trebuhu in dismenoreja.
If you take this medicine while you are breast-feeding a baby, do not breast-feed for one week after taking this medicine. 
Če vzamete to zdravilo v obdobju dojenja, otroka en teden po tem ne dojite.
In vivo results show that the administration of ulipristal acetate with a strong CYP3A4 inducer such as rifampicin markedly decreases Cmax and AUC of ulipristal acetate by 90% or more and decreases ulipristal acetate half-life by 2.2-fold corresponding to an approximately 10-fold decrease of ulipristal acetate exposure. 
Rezultati in vivo so pokazali, da uporaba ulipristalacetata z močnim induktorjem CYP3A4, kot je rifampicin, znatno zmanjša vrednosti Cmax in AUC ulipristalacetata za 90 % ali več ter skrajša razpolovni čas ulipristalacetata za 2,2-krat, kar je enako približno 10-krat manjši izpostavljenosti ulipristalacetatu.
Ulipristal acetate is excreted in breast milk (see section 5.2). 
Ulipristalacetat se izloča v materino mleko (glejte poglavje 5.2).
In addition, the second comparative trial described above also provides data on 100 women treated with ulipristal acetate from 72 to 120 hours after unprotected intercourse, in whom no pregnancies were observed. 
V drugem komparativnem preskušanju, ki je opisano zgoraj in vključuje 100 žensk, ki so prejele ulipristalacetat od 72 do 120 ur po nezaščitenem spolnem odnosu, niso opazili nobene nosečnosti.
Two trials provide efficacy data on ellaOne used up to 120 hours after unprotected intercourse. 
Podatki učinkovitosti dveh kliničnih preskušanj zdravila ellaOne prikazujejo učinkovitost do 120 ur po nezaščitenem spolnem odnosu.
Diarrhoea Dry mouth Dyspepsia Flatulence 
driska suha usta dispepsija flatulenca
- The other ingredients are lactose monohydrate, povidone, croscarmellose sodium, magnesium stearate. 
- Druge sestavine zdravila so laktoza monohidrat, povidon, premreženi natrijev karmelozat in magnezijev stearat.
N pregnancies 0 
Št. nosečnosti
Medicinal product not subject to medical prescription. 
Izdaja zdravila je brez recepta.
If you wish to start or continue with a regular method of contraception after using this medicine, you can do so but you should also use condoms until your next period. 
Če želite po uporabi tega zdravila začeti ali nadaljevati z redno kontracepcijsko metodo, lahko to storite, vendar morate tudi v tem primeru do naslednje menstruacije uporabljati kondome.
The effects of CYP3A4 inhibitors are unlikely to have any clinical consequences. 
Ni verjetno, da bi imeli učinki zaviralcev CYP3A4 kakršne koli klinične posledice.
The carton contains one blister. 
Škatla vsebuje en pretisni omot.
If you have any further questions on the use of this medicine, ask your pharmacist, doctor or other healthcare professional. 
Če imate dodatna vprašanja o uporabi tega zdravila, se posvetujte s farmacevtom, zdravnikom ali drugim zdravstvenim delavcem.
Medicinal products affecting gastric pH 
Zdravila, ki vplivajo na vrednost pH v želodcu
ellaOne is available in a carton containing one blister of 1 tablet. 
Zdravilo ellaOne je na voljo v škatli, ki vsebuje en pretisni omot z eno tableto.
Other medicines and ellaOne 
Druga zdravila in zdravilo ellaOne
If you vomit after taking ellaOne 
Če bruhate po zaužitju zdravila ellaOne
Ulipristal acetate n=34 
Ulipristalacetat n = 34
In vitro data indicate that ulipristal acetate may be an inhibitor of BCRP (Breast Cancer Resistance Protein) transporters at the intestinal level. 
Podatki in vitro kažejo, da je lahko ulipristalacetat zaviralec proteina odpornosti pri raku dojke (BCRP- Breast Cancer Resistance Protein) v črevesju.
Ulipristal acetate also has high affinity for the glucocorticoid receptor and in vivo, in animals, antiglucocorticoid effects have been observed. 
Ulipristalacetat se veže z visoko afiniteto tudi na glukokortikoidne receptorje, v študijah in vivo na živalih pa je bilo opaženo tudi antiglukokortikoidno delovanje.
If you experience these symptoms, do not drive or use machines ellaOne contains lactose 
Če imate te simptome, ne upravljajte vozil ali strojev.
LABORATOIRE HRA PHARMA 200 avenue de Paris 
Imetnik dovoljenja za promet z zdravilom LABORATOIRE HRA PHARMA 200 avenue de Paris
QR code linking to package leaflet to be included Package leaflet online at 
Vključena bo povezava z oznako QR do navodila za uporabo Navodilo za uporabo na spletnem mestu
What you need to know before you take ellaOne Do not take ellaOne 
Kaj morate vedeti, preden boste vzeli zdravilo ellaOne
Concomitant use of ulipristal acetate and emergency contraception containing levonorgestrel is not recommended (see section 4.5). 
Sočasna uporaba ulipristalacetata z nujno kontracepcijo, ki vsebuje levonorgestrel, se ne priporoča (glejte poglavje 4.5).
Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu/. 
Podrobne informacije o zdravilu so objavljene na spletni strani Evropske agencije za zdravila: http://www.ema.europa.eu.
What ellaOne is and what it is used for What you need to know before you take ellaOne How to take ellaOne 
Kaj je zdravilo ellaOne in za kaj ga uporabljamo Kaj morate vedeti, preden boste vzeli zdravilo ellaOne Kako jemati zdravilo ellaOne Možni neželeni učinki
There is no relevant use of ulipristal acetate for children of prepubertal age in the indication emergency contraception. 
Pediatrična populacija Pri otrocih pred puberteto ni ustrezne uporabe za ulipristalacetat pri indikaciji nujne kontracepcije.
Treatment after LH surge but before LH peak n=10 
Jemanje zdravila po zvišanju ravni LH, vendar pred najvišjo ravnjo n = 10
Ulipristal acetate is a lipophilic compound and is distributed in breast milk, with a mean daily excretion of 13.35 µg [0-24 hours], 2.16 µg [24-48 hours], 1.06 µg [48-72 hours], 0.58 µg [72-96 hours], and 0.31 µg [96-120 hours]. 
Izloča se v materino mleko, pri čemer je povprečno dnevno izločanje 13,35 µg [0-24 ur], 2,16 µg [24-48 ur], 1,06 µg [48-72 ur], 0,58 µg [72-96 ur] in 0,31 µg [96120 ur].
If you vomit (be sick, throw up) within 3 hours of taking the tablet, take another tablet as soon as possible. 
Če bruhate v 3 urah po zaužitju tablete, vzemite še eno tableto takoj, ko bo mogoče.
Your doctor may prescribe another type of (non-hormonal) emergency contraceptive, i.e. a copper intrauterine device (Cu-IUD): - medicines used to treat epilepsy (for example, primidone, phenobarbital, phenytoin, 
Zdravnik vam lahko predpiše drugo vrsto (nehormonske) nujne kontracepcije, tj. bakreni maternični vložek (CuIUD): - zdravila za zdravljenje epilepsije (npr. primidon, fenobarbital, fenitoin, fosfenitoin, karbamazepin,
Following oral administration of a single 30 mg dose, ulipristal acetate is rapidly absorbed, with a peak plasma concentration of 176 ± 89 ng/ml occurring approximately 1 hour (0.5-2.0 h) after ingestion, and with an AUC0-∞ of 556 ± 260 ng.h/ml. 
Po enkratnem 30-miligramskem peroralnem odmerku se ulipristalacetat hitro absorbira; najvišja plazemska koncentracija 176 ± 89 ng/ml se pojavi približno 1 uro (0,5-2,0 ure) po zaužitju zdravila, AUC0-∞ pa je 556 ± 260 ng.h/ml.
The effects of ulipristal acetate on BCRP are unlikely to have any clinical consequences. 
Ni verjetno, da bi imeli učinki ulipristalacetata na BCRP kakršne koli klinične posledice.
Administration of ulipristal acetate (10 mg tablet) together with the proton pump inhibitor esomeprazole (20 mg daily for 6 days) resulted in approximately 65% lower mean Cmax, a delayed Tmax (from a median of 0.75 hours to 1.0 hours) and 13% higher mean AUC. 
Uporaba ulipristalacetata (10 mg tablete) v kombinaciji z zaviralcem protonske črpalke, esomeprazolom (20 mg na dan 6 dni), je povzročila približno 65 % manjšo povprečno vrednost Cmax, zapozneli Tmax (z mediane 0,75 ure na 1,0 ure) in 13 % večjo povprečno vrednost AUC.
Titanium dioxide (E171) Polysorbate 80 (E433) Iron oxide yellow (E172) Potassium aluminium silicate (E555) 
(E171), polisorbat 80 (E433), rumeni železov oksid (E172), kalijev aluminijev silikat (E555).
The effects of the P-gp substrates are unlikely to have any clinical consequences. 
Ni verjetno, da bi imeli učinki na substrate P-gp kakršne koli klinične posledice.
You can take the tablet at any time in the menstrual cycle. 
Tableto lahko vzamete v katerem koli času menstrualnega ciklusa.
IUD (intrauterine device) 
Maternični vložek (IUV)
The tablet can be taken at any time during the menstrual cycle. 
Tableto se lahko zaužije kadar koli med menstrualnim ciklusom.
Česká republika 
ČEŠKA
Experience with ulipristal acetate overdose is limited. 
Izkušnje s prevelikim odmerjanjem ulipristalacetata so omejene.
In the absence of specific studies, no alternate dose recommendations for ulipristal acetate can be made. 
Zaradi pomanjkanja specifičnih študij za ulipristalacetat ni mogoče podati priporočil za drugačno odmerjanje.
Do not use this medicine after the expiry date which is on the carton and on the blister after EXP. 
Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na ovojnini in pretisnem omotu poleg oznake EXP. Rok uporabnosti zdravila se izteče na zadnji dan navedenega meseca.
- diarrhoea, heartburn, wind, dry mouth - unusual or irregular vaginal bleeding, heavy/prolonged periods premenstrual syndrome, vaginal irritation or discharge, lesser or greater sex drive - hot flushes - appetite changes, emotional disorders, anxiety, agitation, trouble sleeping, sleepiness, migraine visual disturbances - influenza - acne, skin lesions, itching - fever, chills, malaise 
- driska, zgaga, vetrovi, suha usta - neobičajna ali neredna krvavitev iz nožnice, močne/podaljšane menstruacije, predmenstrualni sindrom, draženje ali izcedek iz nožnice, šibkejši ali močnejši spolni nagon - oblivi vročine - spremembe v apetitu, emocionalne motnje, tesnoba, vznemirjenost, težave s spanjem, zaspanost,
fosphenytoine, carbamazepine, oxcarbazepine and barbiturates) - medicines used to treat tuberculosis (for example, rifampicin, rifabutin) - a treatment for HIV (ritonavir, efavirenz, nevirapine) - a medicine used to treat fungal infections (griseofulvin) - herbal remedies containing St John's wort (Hypericum perforatum). 
okskarbazepin in barbiturati), - zdravila za zdravljenje tuberkuloze (npr. rifampicin, rifabutin), - zdravila za zdravljenje HIV (ritonavir, efavirenz, nevirapin), - zdravilo, s katerim zdravimo okužbe z glivicami (grizeofulvin), - zdravila rastlinskega izvora, ki vsebujejo šentjanževko (Hypericum perforatum).
Adolescents: ulipristal acetate for emergency contraception is suitable for any woman of child bearing age, including adolescents. 
Mladostnice: ulipristalacetat za nujno kontracepcijo je primeren za vsako žensko v rodni dobi, vključno z mladostnicami.
How ellaOne works ellaOne contains the substance ulipristal acetate which acts by modifying the activity of the natural hormone progesterone which is necessary for ovulation to occur. 
Ta deluje tako, da spremeni delovanje naravnega hormona progesterona, ki je potreben za nastop ovulacije.
See leaflet for further information 
Vsebina pakiranja in dodatne informacije
Contraception after ellaOne intake 
Kontracepcija po zaužitju zdravila ellaOne
Administration of ulipristal acetate together with a high-fat breakfast resulted in approximately 45% lower mean Cmax, a delayed Tmax (from a median of 0.75 hours to 3 hours) and 25% higher mean AUC0-∞ compared with administration in the fasted state. 
Če se ulipristalacetat zaužije med zajtrkom z visoko vsebnostjo maščob, se povprečni Cmax zniža približno za 45 %, čas do tmax se podaljša (s srednje vrednosti 0,75 ure na 3 ure), povprečni AUC0-∞ pa se v primerjavi z jemanjem na tešče poviša za 25 %.
ROUMANIA 
ROMUNIJA
Ulipristal acetate does not interrupt an existing pregnancy. 
Ulipristalacetat ne prekine obstoječe nosečnosti.
Concomitant use of ellaOne with CYP3A4 inducers (e.g. barbiturates (including primidone and phenobarbital), phenytoin, fosphenytoin, carbamazepine, oxcarbazepine, herbal medicines containing Hypericum perforatum (St. John's wort), rifampicin, rifabutin, griseofulvin, efavirenz and nevirapine) therefore reduces plasma concentrations of ulipristal acetate and may result in a decreased efficacy of ellaOne. 
Sočasna uporaba zdravila ellaOne in induktorjev CYP3A4 (npr. barbiturati (vključno s primidonom in fenobarbitalom), fenitoin, fosfenitoin, karbamazepin, okskarbazepin, zdravila rastlinskega izvora, ki vsebujejo Hypericum perforatum (šentjanževko), rifampicin, rifabutin, grizeofulvin, efavirenz in nevirapin) tako zmanjša koncentracije ulipristalacetata v plazmi ter lahko posledično zmanjša učinkovitost zdravila ellaOne.
If you miss your period and experience such symptoms after taking ellaOne, you should do a pregnancy test (see section 2 “Pregnancy, breastfeeding and fertility”). 
Če niste dobili menstruacije in so se pri vas pojavili takšni simptomi po uporabi zdravila ellaOne, morate opraviti test nosečnosti (glejte poglavje 2 »Nosečnost, dojenje in plodnost«).
Concomitant use of ellaOne with CYP3A4 inducers is not recommended due to interaction (e.g. barbiturates (including primidone and phenobarbital), phenytoin, fosphenytoin, carbamazepine, oxcarbazepine, herbal medicinal products containing Hypericum perforatum (St. John's wort), rifampicin, rifabutin, griseofulvin, efavirenz, nevirapine and long term use of ritonavir). 
Sočasne uporabe zdravila ellaOne z induktorji CYP3A4 se zaradi medsebojnega delovanja ne priporoča (npr. barbiturati (vključno s primidonom in fenobarbitalom), fenitoin, fosfenitoin, karbamazepin, okskarbazepin, zdravila rastlinskega izvora, ki vsebujejo Hypericum perforatum (šentjanževko), rifampicin, rifabutin, grizeofulvin, efavirenz, nevirapin in dolgotrajna uporaba ritonavirja).
Pregnancy, breast-feeding and fertility 
Nosečnost, dojenje in plodnost Nosečnost
Emergency contraception within 120 hours (5 days) of unprotected sexual intercourse or contraceptive failure. 
Nujna kontracepcija v 120 urah (5 dneh) po nezaščitenem spolnem odnosu ali neučinkoviti kontracepciji.
Rare side effects (may affect up to 1 in 1,000 people) 
Redki neželeni učinki (pojavijo se lahko pri največ 1 od 1.000 bolnikov):
Ulipristal acetate is extensively metabolised to mono-demethylated, di-demethylated and hydroxylated metabolites. 
Ulipristalacetat se večinoma presnavlja v monodemetilirane, didemetilirane in hidroksilirane presnovke.
Uncommon side effects (may affect up to 1 in 100 people) 
Občasni neželeni učinki (pojavijo se lahko pri največ 1 od 100 bolnikov):
During this time, it is recommended to use a breast pump in order to maintain milk production, but throw away your breast milk. 
V tem času vam priporočamo, da si mleko iztiskate s prsno črpalko in ga zavržete, da tako ohranite zmožnost dojenja.
If you have sex again after taking ellaOne 
Če imate po zaužitju zdravila ellaOne ponovno spolne odnose
In vivo results show that administration of ulipristal acetate with a potent and a moderate CYP3A4 inhibitor increased Cmax and AUC of ulipristal acetate with a maximum of 2- and 5.9-fold, respectively. 
Rezultati in vivo so pokazali, da je uporaba ulipristalacetata z močnim in zmernim zaviralcem CYP3A4 povečala vrednosti ulipristalacetata Cmax za 2-krat in AUC za 5,9-krat.
Tablet White to marble creamy, round curved tablet of 9 mm diameter engraved with “еllа” on both sides. 
Bela oz. kremasta marmorirana, okrogla, zaobljena tableta premera 9 mm z vtisnjeno oznako „ella“ na obeh straneh.
If you miss your period and experience such symptoms after taking ellaOne, you should do a pregnancy test (See section “Pregnancy, breastfeeding and fertility”). 
Če niste dobili menstruacije in so se pri vas pojavili takšni simptomi po uporabi zdravila ellaOne, morate opraviti test nosečnosti (glejte poglavje »Nosečnost, dojenje in plodnost«).
For example: - if you had sex without protection; - if your or your partner's condom tore, slipped or came off, or if you forgot to use one; - if you did not take your contraceptive pill as recommended. 
Zdravilo ellaOne je kontracepcijsko sredstvo, namenjeno preprečitvi nosečnosti po nezaščitenem spolnem odnosu ali ko je kontracepcijska metoda neučinkovita, na primer: - če ste imeli nezaščiten spolni odnos; - če se je vaš kondom ali kondom vašega partnerja strgal, zdrsnil ali se snel ali če ste ga pozabili uporabiti; - če niste jemali kontracepcijskih tablet po navodilih.
You must take this medicine within 120 hours (5 days) of unprotected sex or contraceptive failure. 
Zdravilo morate vzeti v 120 urah (5 dneh) po nezaščitenem spolnem odnosu ali neučinkoviti kontracepciji.
Weekly or monthly methods 
Primeri rednih kontracepcijskih metod: Dnevne metode Kontracepcijska tableta Tedenske ali mesečne metode Kontracepcijski obliž
Pregnancy may occasionally occur after ulipristal acetate intake. 
Po uporabi ulipristalacetata lahko občasno nastopi nosečnost.
PVC-PVDC (with UV filter) / Aluminium blister of 1 tablet. 
Pretisni omot iz PVC-PVDC-aluminija (z UV-filtrom) z eno tableto.
If you become pregnant despite taking this medicine, it is important that you see your doctor. 
Če kljub uporabi tega zdravila zanosite, nujno obiščite svojega zdravnika.
Ulipristal acetate inhibits or postpones ovulation (see section 5.1). 
Ulipristalacetat zavre ali odloži ovulacijo (glejte poglavje 5.1).
PVC-PE-PVDC-Aluminium blister of 1 tablet. 
Pretisni omot iz PVC-PE-PVDC-aluminija z eno tableto.
CROATIA 
HRVAŠKA
Pharmacotherapeutic group: Sex hormones and modulators of the genital system, emergency contraceptives. 
Farmakoterapevtska skupina: spolni hormoni in zdravila za uravnavanje delovanja spolovil, urgentni kontraceptivi, oznaka ATC: G03AD02.
Tablet core: lactose monohydrate, povidone, croscarmellose sodium, magnesium stearate Film coating: poly(vinyl alcohol) (E1203), macrogol (E1521), talc (E553b), titanium dioxide (E171), polysorbate 80 (E433), iron oxide yellow (E172), potassium aluminium silicate (E555) 
Filmska obloga: polivinilalkohol (E1203) makrogol (E1521) smukec (E533b) titanov dioksid (E171) polisorbat 80 (E433) železov oksid, rumeni (E172) kalijev aluminijev silikat (E555)
Talk to your pharmacist, doctor or other healthcare professional before taking this medicine - if your period is late or you have symptoms of pregnancy (heavy breasts, morning sickness), as you may already be pregnant (see section “Pregnancy, breast-feeding and fertility”); - if you suffer from severe asthma; - if you suffer from severe liver disease. 
- če vam menstruacija zamuja ali imate simptome nosečnosti (težke prsi, jutranja slabost), saj ste morda že noseči (glejte poglavje »Nosečnost, dojenje in plodnost«); - če imate hudo astmo; - če imate hudo bolezen jeter.
If you are currently taking hormonal contraception, continue to use it as usual after taking this medicine, but be sure to use condoms every time you have sex until your next period. 
Če trenutno jemljete hormonsko kontracepcijo, jo po uporabi tega zdravila še naprej uporabljajte kot običajno, vendar morate do naslednje menstruacije uporabiti kondom vsakič, ko imate spolne odnose.
Adverse reactions (frequency) System organ class Common 
Neželeni učinki (pogostnost)
Placebo n=50 
Preprečitev ovulacije1,§ Placebo n = 50
Film-coated tablet 
FARMACEVTSKA OBLIKA filmsko obložena tableta
Poly(vinyl alcohol) (E1203) Macrogol (E1521) Talc (E553b) 
- Filmska obloga: polivinilalkohol (E1203), makrogol (E1521), smukec (E553b), titanov dioksid
The treatment consists of one tablet to be taken orally as soon as possible, but no later than 120 hours (5 days) after unprotected intercourse or contraceptive failure. 
Zdravljenje poteka peroralno, in sicer se zaužije ena tableta čim prej, vendar najkasneje 120 ur (5 dni) po nezaščitenem spolnem odnosu ali neučinkoviti kontracepciji.
You can also report this information on your own at www.hra-pregnancy-registry.com.Your information will remain anonymous - nobody will know it is information about you. 
O tem lahko poročate tudi sami na spletnem naslovu www.hra-pregnancy-registry.com.
- Take one tablet by mouth as soon as possible and no later than 5 days (120 hours) after unprotected sex or contraceptive failure. 
- Zaužijte eno tableto čim prej, najpozneje pa 5 dni (120 ur) po nezaščitenem spolnem odnosu ali neučinkoviti kontracepciji.
If you are currently taking hormonal contraception, continue to use it as usual after taking the tablet, but be sure to use condoms every time you have sex until your next period. 
Če trenutno jemljete hormonsko kontracepcijo, jo po uporabi tablete še naprej uporabljajte kot običajno, vendar morate do naslednje menstruacije uporabiti kondom vsakič, ko imate spolne odnose.
In vitro data indicate that ulipristal acetate may be an inhibitor of P-gp at clinically relevant concentrations. 
Podatki in vitro kažejo, da je lahko ulipristalacetat v klinično pomembnih koncentracijah zaviralec Pglikoproteina.
No differences in safety or efficacy have been shown compared to adult women aged 18 and older (see section 5.1). 
V varnosti in učinkovitosti niso opazili nobenih razlik v primerjavi z odraslimi ženskami, starimi
A. 
NS*
Speak to your doctor or pharmacist before using ellaOne. 
Pred uporabo zdravila ellaOne se posvetujte z zdravnikom ali farmacevtom.
What ellaOne looks like and contents of the pack ellaOne is a golden film-coated tablet of shield shape (around 10.8 mm diameter) with “ella” engraved on both sides. 
Izgled zdravila ellaOne in vsebina pakiranja Zdravilo ellaOne je filmsko obložena tableta zlate barve v obliki ščita (približnega premera 10,8 mm)
What ellaOne looks like and contents of the pack ellaOne is a white to marble creamy, round curved tablet of 9 mm diameter engraved with “еllа” on both sides. 
Zdravilo ellaOne je bela do kremasta marmorirana, okrogla, zaobljena tableta premera 9 mm z oznako „ella“ na obeh straneh.
If you have unprotected sex after taking this medicine, it will not stop you from becoming pregnant. 
Če imate nezaščiten spolni odnos po zaužitju tega zdravila, zdravilo ne bo preprečilo zanositve.
Deutschland 
NEMČIJA
PVC-PVDC-Aluminium blister of 1 tablet. 
Pretisni omot iz PVC-PVDC-aluminija z eno tableto.
How to take the ellaOne tablet 
Kako jemati zdravilo ellaOne
HRA Pharma Benelux Tél/Tel: +32 2 709 2295 
Luxembourg/Luxemburg HRA Pharma Benelux Tél/Tel: +32 2 709 2295
You are advised to speak to a healthcare professional if you are concerned about any problems related to taking emergency contraception. 
Če ste zaskrbljeni glede kakršnih koli težav, povezanih z jemanjem nujne kontracepcije, je priporočljivo, da se posvetujete z zdravstvenim delavcem.
After you take the tablet and until your next period comes, you should use condoms every time you have sex. 
Po tem, ko ste vzeli tableto in do naslednje menstruacije morate uporabiti kondom vsakič, ko imate spolne odnose.
A. MANUFACTURERS RESPONSIBLE FOR BATCH RELEASE 
A. IZDELOVALCI, ODGOVORNI ZA SPROŠČANJE SERIJ Ime in naslov izdelovalcev, odgovornih za sproščanje serij Cenexi
Τηλ: + 30-(0) 210 66 83 000 
ΑΡΡΙΑΝΙ ΦΑΡΜΑΚΕΥΤΙΚΗ ΑΕ Τηλ: + 30-(0)210 66 83 000